Tommy Tuberville’s recent stock transactions have once again drawn scrutiny, particularly his purchases of $HUMA shares, known for their tissue implant technology, just before the Ukraine conflict escalated. His position on the Armed Services Committee adds another layer of concern, highlighting potential conflicts of interest. The lack of transparency and regulation surrounding congressional stock trading fuels accusations of insider dealings and war profiteering, casting a shadow over the integrity of legislative decision-making.
The gift that keeps on giving when it comes to shady dealings and conflicts of interest. Not only is he sitting on the Armed Services Committee, but he's also trading in stocks that benefit from war. #WarProfiteering
And it's not like he's being subtle about it either. He's…
— Joe (@JoeMaristela) April 16, 2024